phenelzine has been researched along with Fatigue Syndrome, Chronic in 1 studies
Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Natelson, BH | 1 |
| Cheu, J | 1 |
| Pareja, J | 1 |
| Ellis, SP | 1 |
| Policastro, T | 1 |
| Findley, TW | 1 |
1 trial available for phenelzine and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome.
Topics: Adult; Double-Blind Method; Fatigue Syndrome, Chronic; Female; Humans; Male; Monoamine Oxidase Inhib | 1996 |